Latest News & Features
Americas
Teva and Spectrum Pharmaceuticals have settled a patent dispute over the generic version of Folotyn, a treatment for patients with relapsed or refractory peripheral T-cell lymphoma. 27 May 2016
Americas
Law firm McMillan has hired Stuart Kruger as a partner in the firm’s pharmaceuticals and biotechnology practice in Montreal. 26 May 2016
Americas
Egalet Corporation announced that it has reached an agreement with Purdue Pharma regarding the alleged patent infringements by Egalet and product licensor Acura Pharmaceuticals through Oxaydo tablets. 25 May 2016
Americas
Monsanto has rejected Bayer’s $62 billion buyout offer that would have created the world’s largest agricultural supplier, calling the bid “incomplete and financially inadequate”, but said it was open to negotiate further. 25 May 2016
Big Pharma
Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion. 24 May 2016
article
China has said that it will reduce the price of three top-selling patented drugs by more than 50%. 24 May 2016
Americas
Colombia’s health ministry has warned Novartis that it might override a patent that the company owns covering cancer drug Gleevec. 20 May 2016
Americas
Law firm Lathrop & Gage has hired Alan Steele as a counsel in its intellectual property practice group in Boston. 19 May 2016
Europe
Bayer and ERS Genomics have signed a patent licensing agreement which gives Bayer access to ERS’s CRISPR/Cas9 genome-editing patents. 19 May 2016
Americas
Amgen has sued Sandoz for allegedly infringing two patents related to cancer drug Neulasta, following Sandoz’s plans to sell a biosimilar version of the drug. 19 May 2016